-
Forward Look
Affordable Care Act to Cover Breast Cancer Risk Reduction DrugsMedications are an option for high-risk women, but few use them.
by Sue Rochman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
-
Forward Look
Moving Closer to a Menthol Ban?FDA weighs whether to prohibit sales of mentholated tobacco products.
by Sharon Reynolds
-
Forward Look
Cancer Death Rates Continue to Decline in U.S.Statistics show impact of prevention, early detection and treatment.
by Cameron Walker
-
Forward Look
Clues to Stomach Cancer Discovered in South AmericaFindings could help in cancer prevention.
by Alexandra Goho
-
Palliative Care ExplainedPalliative care can be offered to cancer patients at any point in their illness, beginning with the initial diagnosis. New research points to its effectiveness.
by Melissa Weber
-
Using Old Drugs in New WaysWe already reduce, reuse and recycle. But cancer researchers are exploring a fourth R–repurpose–using drugs approved for treating other diseases to reduce cancer risk and improve outcomes.
by Stephen Ornes
-
Unleashing the Immune SystemNew treatments that harness the power of the immune system are taking aim at many common cancers.
by Alexandra Goho
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
New Report Finds Crisis in Cancer CareInstitute of Medicine calls for major improvements.
by Stephen Ornes
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
